SVP, Finance and CFO of Fibrogen Inc (30-Year Financial, Insider Trades) Pat Cotroneo (insider trades) sold 15,004 shares of FGEN on 09/03/2020 at an average price of $50.91 a share. The total sale was $763,854.
FibroGen Inc is a biopharmaceutical company. It is engaged in the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs. FibroGen Inc has a market cap of $3.9 billion; its shares were traded at around $43.18 with and P/S ratio of 35.16. FibroGen Inc had annual average EBITDA growth of 18.10% over the past five years. GuruFocus has detected 5 severe warning signs with FibroGen Inc. .
CFO Recent Trades:
- SVP, Finance and CFO Pat Cotroneo sold 15,004 shares of FGEN stock on 09/03/2020 at the average price of $50.91. The price of the stock has decreased by 15.18% since.
- SVP, Finance and CFO Pat Cotroneo sold 22,554 shares of FGEN stock on 08/07/2020 at the average price of $48. The price of the stock has decreased by 10.04% since.
Directors and Officers Recent Trades:
- Chief Medical Officer K Peony Yu sold 10,000 shares of FGEN stock on 09/03/2020 at the average price of $50.89. The price of the stock has decreased by 15.15% since.
For the complete insider trading history of FGEN, click here
.
